Statistics

Total Visits

Views
A randomised, double-blind, parallel-group, phase 1 study comparing the pharmacokinetics, safety and efficacy of ct-p13 and infliximab in patients with active ankylosing spondylitis: 54 week results from the planetas study13

Select a period of time:

Number of views in the range

Views
A randomised, double-blind, parallel-group, phase 1 study comparing the pharmacokinetics, safety and efficacy of ct-p13 and infliximab in patients with active ankylosing spondylitis: 54 week results from the planetas study11

Views

Views
November 20231
December 20232
January 20246
February 20240
March 20241
April 20241
May 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States11
 

Top cities views

Views
Boardman8
Chicago1
Seattle1